WCM
RPRX icon

Wedge Capital Management’s Royalty Pharma RPRX Stock Holding History

Wedge Capital Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.2M Sell
770,422
-120,418
-14% -$6.27M 0.71% 28
2026
Q1 		$42.7M Sell
890,840
-149,128
-14% -$6.53M 0.79% 29
2025
Q4 		$40.2M Sell
1,039,968
-152,473
-13% -$5.81M 0.72% 30
2025
Q3 		$42.1M Sell
1,192,441
-22,480
-2% -$814K 0.71% 30
2025
Q2 		$43.8M Buy
1,214,921
+200,122
+20% +$6.63M 0.78% 28
2025
Q1 		$31.6M Buy
+1,014,799
New +$32.2M 0.61% 80

Other funds holding RPRX

EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KMC
Kirr Marbach & Co Columbus, Indiana $594M AUM 34% 1-Year Est. Return
CI
Cooper Investors Melbourne, Victoria, Australia $218M AUM 0.39% 1-Year Est. Return
BG
BDF Gestion Paris, France $747M AUM 47.35% 1-Year Est. Return
FIC
FCG Investment Company Germantown, Tennessee $289M AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
MGI
Miller Global Investments Dallas, Texas $121M AUM
WPC
Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return